Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes.
Helicobacter pylori and autoimmune disease: Cause or bystander.
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Onion-shaped white matter disease?
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance.
Endogenous recovery after brain damage; molecular mechanisms that balance neuronal life/death fate.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study.
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
The use of immune modulating drugs for the treatment of multiple sclerosis.
Immunomodulation by Sub-Chronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis.
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Pages
« first
‹ previous
…
549
550
551
552
553
554
555
556
557
…
next ›
last »